 |
NBE Therapeutics
Last updated: August 22, 2024
Ulf Grawunder - founder and CEO
Switzerland | Funding: $65.7M (+)
Website: http://www.nbe-therapeutics.com
NBE-Therapeutics develops next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
Website: http://www.nbe-therapeutics.com
NBE-Therapeutics develops next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
